Prospects of electrochemical immunosensors for early diagnosis of preeclampsia.
Preeclampsia is a vascular multisystem disorder that accounts for varying degree of morbidity and mortality of mother and the fetus. This can be significantly averted if diagnosed at an early (18-20 weeks) stage of gestation, as there is no known way to prevent preeclampsia. In spite of extensive work on biomarker discovery, the existing method for its detection is mostly based on colorimetric immunoassays whose sensitivity is ranging in nanomolar range. Further, it has also been observed that change in the expression of a single biomarker is not sufficient to diagnose this condition. So, for early diagnosis (by 18-20 weeks), an immuno-diagnostic platform with detection limits in picomolar range and beyond along with the ability to do simultaneous detection of multiple analyte would be of great importance. A nano-immunosensors with an electrochemical readout system can be a potential alternative that promises for the ultrasensitive detection of analyte with high specificity as well as suitability for on-site analysis. Coupling the lateral flow technology with immunosensors would make it feasible to detect more than one biomarker simultaneously on a microchip. This review intends to summarize the potential preeclampsia biomarkers, limitations of existing diagnostic methods along with the recent advancements, and prospects to develop electrochemical immunosensors for early clinical diagnosis.
Veterianry Hospital Dhanarua, Animal and Fishery Resources Department (Govt. of Bihar), Patna, Bihar, India.
Pankaj
P
Suman
Amity Institute of Biotechnology, Amity University Uttar Pradesh, Noida, Uttar Pradesh, India.
Sonu
S
Gandhi
Amity Institute of Biotechnology, Amity University Uttar Pradesh, Noida, Uttar Pradesh, India.
Prabhanshu
P
Kumar
Amity Institute of Biotechnology, Amity University Uttar Pradesh, Noida, Uttar Pradesh, India.
Kirti
K
Garg
D015415:Biomarkers / Q000378:metabolism*; D042241:Early Diagnosis; D055664:Electrochemical Techniques / Q000379:methods / Q000639:trends; D005260:Female; D005865:Gestational Age; D006801:Humans; D007118:Immunoassay / Q000379:methods; D056656:Lab-On-A-Chip Devices / Q000706:statistics & numerical data*; D036103:Nanotechnology; D011225:Pre-Eclampsia / Q000175:diagnosis*; D011247:Pregnancy; D012680:Sensitivity and Specificity
D015415:Biomarkers
biomarker; immunosensors; preeclampsia; pregnancy